Heart drugs tested as potential COVID-19 lifesaver
NCT ID NCT04591210
Summary
This international study investigated whether starting common blood pressure medications (ACE inhibitors or ARBs) could help high-risk COVID-19 patients. Researchers enrolled 372 hospitalized and outpatient adults who tested positive for COVID-19 and weren't already taking these medications. They compared starting one of these drugs versus no treatment to see if it reduced severe outcomes like ICU admission, ventilator need, or death, and also tracked long-term quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR DISEASES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Alberta Health Services
Edmonton, Alberta, Canada
-
Centro de Pesquisa Clinica da Unimed Campo Grande
Campo Grande, Minas Gerais, Brazil
-
Centro de Pesquisa Clinicas Dr Marco Mota
Maceió, Alagoas, Brazil
-
Centro de Pesquisas em Diabetes e Doencas Endocrino-Metabolicas
Fortaleza, Ceará, 60-430-350, Brazil
-
Clinica de Campo Grande
Campo Grande, Minas Gerais, Brazil
-
Hospital Agamenom Magalhaes
Recife, Pernambuco, Brazil
-
Hospital Bela Vista
Consolação, São Paulo, Brazil
-
Hospital Eduardo Campos da Pessoa Idosa
Estância, Recife, 50870-901, Brazil
-
Hospital Felicio Rocho
Belo Horizonte, Minas Gerais, Brazil
-
Hospital General 1, IMSS
Mexico City, Mexico
-
Hospital General Regional No 2
El Marqués, Querétaro, 76269, Mexico
-
Hospital General de Zona 20
La Margarita, Puebla, 72560, Mexico
-
Hospital General de zona 27- IMSS
Mexico City, Mexico
-
Hospital General zona 11
Xalapa, Veracruz, 91000, Mexico
-
Hospital Sao Lucas da PUCRS
Porto Alegre, Rio Grande do Sul, 90610-000, Brazil
-
Hospital Sao Vicente de Paulo
Passo Fundo, Rio Grande do Sul, Brazil
-
Hospital Universitar Canoas
Canoas, Rio Grande do Sul, Brazil
-
Hospital Universitario Sao Francisco na Providencia de Deus
Bragança Paulista, São Paulo, 12916-542, Brazil
-
Hospital de Infectologia Dr Daniel Mendez Fernandez
Azcapotzalco, Mexico City, 06900, Mexico
-
Hospital de Julho
São Paulo, São Paulo, 01409-901, Brazil
-
Instituto Atena de Pesquisa Clinica
Natal, Rio Grande do Norte, Brazil
-
Instituto Goiano de Oncologia e Hematologia
Goiânia, Brazil
-
Instituto Prevent Senior
São Paulo, São Paulo, Brazil
-
Instituto de Coracao
São Paulo, São Paulo, Brazil
-
Instituto de Pesquisa Clinica de Campinas
Campinas, São Paulo, Brazil
-
Nucleo de Pesquisa Clinica SS
Curitiba, Paraná, 80730-150, Brazil
-
Pronto Socorro Cardiologico de Pernambuco Recife
Recife, Pernambuco, Brazil
-
Santa Casa de Itabuna
Itabuna, Estado de Bahia, Brazil
-
Unidad de Medicina Familiar No 10
Xalapa, Veracruz, 91000, Mexico
-
Unidad de Medicina Familiar No 77
Ecatepec de Morelos, State of Mexico, Mexico
-
University of Ottawa Heart Institute
Ottawa, Ontario, Canada
Conditions
Explore the condition pages connected to this study.